SAGE Therapeutics Inc (NASDAQ:SAGE)
| 20.00 BATS BZX Real-Time Price As of 12:09pm ET |  -0.58 / -2.82%Today’s Change | 16.52 Today|||52-Week Range 59.99 | -47.56% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 90.3M | |
| Depreciation And Amortization | 115.0K | 281.0K | 531.0K | 1.1M | ||
| Operating Expenses | Gross Income | -115.0K | -281.0K | -531.0K | -- | |
| General Expenses | 94.5M | 159.9M | 272.6M | 482.4M | ||
| Research And Development | 69.4M | 120.8M | 210.3M | 282.1M | ||
| Total Operating Expenses | 94.7M | 160.2M | 273.2M | 483.5M | ||
| Non-Operating Expenses | Operating Income | -94.7M | -160.2M | -273.2M | -393.2M | |
| Other Expenses | -23.0K | -35.0K | -64.0K | 22.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -94.5M | -159.0M | -270.1M | -372.9M | |
| Net Income | -94.5M | -159.0M | -270.1M | -372.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 27.8M | 33.5M | 38.1M | 46.1M | |
| Shares To Calculate EPS Diluted | 27.8M | 33.5M | 38.1M | 46.1M | ||
| Earnings Per Share | EPS | -$3.40 | -$4.75 | -$7.09 | -$8.08 | |
| EPS Diluted | -$3.40 | -$4.75 | -$7.09 | -$8.08 | ||
